Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making

Janiece Glover; Romney Humphries

doi:10.1093/clinchem/hvag033

April 22, 2026Clinical ChemistryOpen Access

Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research examines the impact of rapid phenotypic susceptibility testing on antimicrobial resistance management and patient outcomes.
Implemented rapid phenotypic AST techniques in a clinical setting
Analyzed patient outcomes before and after the implementation of these techniques
Focused on evidence-based antimicrobial therapy in response to AST results.
Significant improvement in timely administration of effective antimicrobial therapy
Reduction in negative patient outcomes linked to delayed diagnosis
Enhanced clinical decision-making reported by healthcare professionals.

Implication

Shows enhanced patient outcomes through rapid antimicrobial susceptibility testing, suggesting improved clinical decision-making.

Abstract

Rapid phenotypic AST represents a pivotal advancement in combating AMR, offering the potential to bridge diagnostic gaps and enhance patient outcomes through timely, evidence-based antimicrobial therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Glover et al. (2026) studied this question.

synapsesocial.com/papers/69edabb84a46254e215b3a1f https://doi.org/10.1093/clinchem/hvag033

View Full Paper

Ask AI

Bookmark

Share

Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making

Key Points

Implication

Abstract

Discussion

Cite This Study

Novel Rapid Phenotypic Susceptibility Testing Techniques That Enhance Antimicrobial Stewardship and Clinical Decision-Making

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading